These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17148251)

  • 1. The cost of replication fidelity in human immunodeficiency virus type 1.
    Furió V; Moya A; Sanjuán R
    Proc Biol Sci; 2007 Jan; 274(1607):225-30. PubMed ID: 17148251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations.
    Maldonado JO; Mansky LM
    Viruses; 2018 Jul; 10(7):. PubMed ID: 30029500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high cost of fidelity.
    Lloyd SB; Kent SJ; Winnall WR
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):8-16. PubMed ID: 24180375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelationship between HIV-1 fitness and mutation rate.
    Dapp MJ; Heineman RH; Mansky LM
    J Mol Biol; 2013 Jan; 425(1):41-53. PubMed ID: 23084856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation in the primer grip region of HIV-1 reverse transcriptase that confers reduced fidelity of DNA synthesis.
    Gutiérrez-Rivas M; Menéndez-Arias L
    Nucleic Acids Res; 2001 Dec; 29(24):4963-72. PubMed ID: 11812826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses.
    Wei X; Liang C; Götte M; Wainberg MA
    AIDS; 2002 Dec; 16(18):2391-8. PubMed ID: 12461412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity.
    White KL; Margot NA; Wrin T; Petropoulos CJ; Miller MD; Naeger LK
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3437-46. PubMed ID: 12384348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication.
    Abram ME; Ferris AL; Shao W; Alvord WG; Hughes SH
    J Virol; 2010 Oct; 84(19):9864-78. PubMed ID: 20660205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside-analog resistance mutations in HIV-1 reverse transcriptase and their influence on polymerase fidelity and viral mutation rates.
    Rezende LF; Prasad VR
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1716-34. PubMed ID: 15183340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of fidelity of DNA synthesis and nucleotide specificity of retroviral reverse transcriptases.
    Menéndez-Arias L
    Prog Nucleic Acid Res Mol Biol; 2002; 71():91-147. PubMed ID: 12102562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication.
    Abram ME; Ferris AL; Das K; Quinoñes O; Shao W; Tuske S; Alvord WG; Arnold E; Hughes SH
    J Virol; 2014 Jul; 88(13):7589-601. PubMed ID: 24760888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends.
    Patel PH; Preston BD
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):549-53. PubMed ID: 7507249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High fidelity simian immunodeficiency virus reverse transcriptase mutants have impaired replication in vitro and in vivo.
    Lloyd SB; Lichtfuss M; Amarasena TH; Alcantara S; De Rose R; Tachedjian G; Alinejad-Rokny H; Venturi V; Davenport MP; Winnall WR; Kent SJ
    Virology; 2016 May; 492():1-10. PubMed ID: 26896929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors.
    Hu Z; Kuritzkes DR
    J Virol; 2014 Aug; 88(16):9268-76. PubMed ID: 24899199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates.
    Boyer JC; Bebenek K; Kunkel TA
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6919-23. PubMed ID: 1379727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1.
    Hsu M; Inouye P; Rezende L; Richard N; Li Z; Prasad VR; Wainberg MA
    Nucleic Acids Res; 1997 Nov; 25(22):4532-6. PubMed ID: 9358162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the fitness cost of escape from HLA presentation in HIV-1 protease and reverse transcriptase.
    Mostowy R; Kouyos RD; Hoof I; Hinkley T; Haddad M; Whitcomb JM; Petropoulos CJ; Keşmir C; Bonhoeffer S
    PLoS Comput Biol; 2012; 8(5):e1002525. PubMed ID: 22654656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.
    Mansky LM; Temin HM
    J Virol; 1995 Aug; 69(8):5087-94. PubMed ID: 7541846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
    J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 reverse transcription.
    Hu WS; Hughes SH
    Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.